CLOV vs XBIO · rev $1.37B vs rev $2.5M
Clover Health Investments Corp (CLOV) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported XBIO revenue for 2024-12-31 was $2.5M. Net income was -$4.0M. Revenue was down 1.6% from 2023-12-31 to 2024-12-31. XBIO currently screens at market cap $5.7M.
CLOV currently screens at market cap $1.55B. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the CLOV and XBIO stock pages for the full models.
Not investment advice.